Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/12087
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSavelkoel Jen
dc.contributor.authorDance DABen
dc.contributor.authorCurrie BJen
dc.contributor.authorLimmathurotsakul Den
dc.contributor.authorWiersinga WJen
dc.date.accessioned2022-01-05T05:35:43Zen
dc.date.available2022-01-05T05:35:43Zen
dc.date.issued2021-12-23en
dc.identifier.citationCopyright © 2021 Elsevier Ltd. All rights reserved.en
dc.identifier.citationLancet Infect Dis. 2021 Dec 23:S1473-3099(21)00394-7. doi: 10.1016/S1473-3099(21)00394-7.en
dc.identifier.other101130150en
dc.identifier.urihttps://hdl.handle.net/10137/12087en
dc.description.abstractMelioidosis is a tropical infection caused by the soil bacterium Burkholderia pseudomallei. Despite the substantial impact of this often overlooked pathogen on both the health-care systems and economies of numerous low-income and middle-income countries around the world, melioidosis is not officially classified as a neglected tropical disease (NTD) by WHO. Melioidosis causes a higher estimated disease burden and mortality than many other recognised NTDs, with deaths primarily occurring among rural poor populations in low-income and middle-income countries. Fortunately, the impact of melioidosis in a region can be reduced once awareness is established of its known or suspected endemicity. In this Personal View, we provide evidence in support of official recognition of melioidosis as an NTD. We urge member states to request that WHO revisit their NTD list and appeal to government and philanthropic organisations to establish programmes in endemic countries to control melioidosis in order to reduce its global health burden.en
dc.language.isoengen
dc.titleA call to action: time to recognise melioidosis as a neglected tropical disease.en
dc.typeJournal Articleen
dc.typeReviewen
dc.publisher.placeUnited Statesen
dc.identifier.journaltitleThe Lancet. Infectious diseasesen
dc.identifier.doi10.1016/S1473-3099(21)00394-7en
dc.identifier.pubmedurihttps://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/34953519en
dc.description.affiliationCenter for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.en
dc.description.affiliationLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.en
dc.description.affiliationGlobal and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Infectious Diseases Department and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, NT, Australia.en
dc.description.affiliationCentre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Department of Tropical Hygiene and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.en
dc.description.affiliationCenter for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Division of Infectious Diseases, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: w.j.wiersinga@amsterdamumc.nl.en
local.issue.number1474-4457 (Electronic)-
local.issue.number1473-3099 (Linking)-
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing

Pubmed

PubMed References

Who's citing